New Treatments for Migraines: What Actually Works in 2025? Introduction Migraine affects approximately 10% of the global population, including 25% of adult women and 9% of children. It ranks as the third leading cause of years lived with disability, according to the 2019 Global Burden of Disease
Author: Nancy Ogbonna
Mpox and Other Zoonoses: Are We Prepared for the Next Spillover?
Remyelination in MS: Scientists Uncover Promising Treatment Pathway
Remyelination in MS: Scientists Uncover Promising Treatment Pathway Introduction Multiple sclerosis (MS) research has entered a transformative phase with the emergence of two promising therapies aimed at restoring myelin, the protective sheath around nerve fibers that is progressively damaged in MS. Affecting an estimated 2.5 million
Is There a Tuberculosis Vaccine? New Research Brings Fresh Hope in 2025
Is There a Tuberculosis Vaccine? New Research Brings Fresh Hope in 2025 Introduction Tuberculosis claims 1.6 million lives annually, yet the question remains: is there a tuberculosis vaccine that effectively protects adults? Despite the century-old Bacillus Calmette–Guérin (BCG) vaccine’s availability, its limited efficacy in preventing adult pulmonary
Silent Warning Signs: Why Stroke Rates Are Surging Among People Under 40
Is Clonal Hematopoiesis a New Cardiovascular Risk Factor?
Is Clonal Hematopoiesis a New Cardiovascular Risk Factor? Check back later for a possible video summary. Videos are created for most articles. Abstract This paper explores growing evidence that links clonal hematopoiesis, particularly clonal hematopoiesis of indeterminate potential (CHIP), to an increased risk of
Stroke Technology in 2025: New Treatments Giving Patients a Second Chance
Breakthrough: New Alzheimer’s Disease Research Shows Prevention Potential in Clinical Trials
Breakthrough: New Alzheimer’s Disease Research Shows Prevention Potential in Clinical Trials Please like and subscribe if you enjoyed this video :-) Introduction Recent Alzheimer’s disease research reveals a substantial shift from treatment to prevention strategies, offering new hope for millions worldwide. Clinical
The Gut-Brain Connection: How Your Microbiome Affects Neurological Health
New Anticoagulants vs LMWH in Cancer-Associated Thrombosis: Latest Evidence
New Anticoagulants vs LMWH in Cancer-Associated Thrombosis: Latest Evidence Please like and subscribe if you enjoyed this video :-) Introduction Venous thromboembolism (VTE), encompassing deep vein thrombosis and pulmonary embolism, remains one of the most common and life-threatening complications in patients with cancer.
